October 11th 2021, 5:30pm
An evaluation of price transparency tools for ophthalmologic procedures found significant usability, availability, and variability issues, which may disproportionately impact vulnerable populations.
October 9th 2021, 6:08pm
The pathway outlines a 4-step screening process for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
October 9th 2021, 4:30pm
Patients with psoriatic arthritis (PsA) were found to be more likely to report musculoskeletal symptoms and dermatologic issues prior to initial PsA diagnosis.
October 8th 2021, 3:00pm
Pediatric patients with extreme obstructive sleep apnea (OSA) may have a higher risk of needing respiratory support after undergoing corrective adenotonsillectomy, warranting the need for postoperative observation in these populations.
October 8th 2021, 1:45pm
Psychographics is a way of categorizing someone based on their everyday behaviors using data that are collected every time they go to the store or post on social media, said Robert Groves, MD, executive vice president and chief medical officer at Banner | Aetna. In health care, psychographics can be used to positively influence someone to their benefit.
October 7th 2021, 11:47pm
There is a lot of evidence on the disparities in cancer care, but less on how to take those findings and turn them into actionable items to address the problem, said Karen Winkfield, MD, PhD, executive director of the Meharry-Vanderbilt Alliance.
October 7th 2021, 5:00pm
Sepsis is poorly understood, difficult to identify, and even harder to predict. Consistent stakeholder involvement may be key to identifying precisely where and how a sepsis early warning system could improve the team-based response to the condition.
October 7th 2021, 1:00pm
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
October 6th 2021, 6:44pm
Patients with moderate to severe psoriasis were shown to achieve and maintain higher levels of complete skin clearance and quality of life when treated with brodalumab vs ustekinumab, regardless of the presence of lifestyle risk factors.
October 5th 2021, 6:30pm
Male patients with young-onset type 2 diabetes were found to be at 72% greater risk of retinopathy compared with those who received a diagnosis at 50 years or older.
